0001104659-24-039117.txt : 20240326
0001104659-24-039117.hdr.sgml : 20240326
20240326172755
ACCESSION NUMBER: 0001104659-24-039117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240326
DATE AS OF CHANGE: 20240326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ferguson Toby
CENTRAL INDEX KEY: 0002015616
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37625
FILM NUMBER: 24784828
MAIL ADDRESS:
STREET 1: VOYAGER THERAPEUTICS, INC.
STREET 2: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Voyager Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640266
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 857-259-5340
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
tm249758-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-25
0
0001640266
Voyager Therapeutics, Inc.
VYGR
0002015616
Ferguson Toby
C/O VOYAGER THERAPEUTICS, INC.
75 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
9.26
2024-03-25
4
A
0
210000
0
A
2034-03-25
Common Stock
210000
210000
D
This stock option was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4).
The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee.
/s/ Scott MacDonald, as Attorney-in-Fact for Toby Ferguson
2024-03-26